MHUAF Meihua International Medical Technologies Co., Ltd.

Overview and Growth

In fiscal 2025, Meihua International Medical Technologies Co., Ltd. recorded $61.79M of revenue, net income of $6.78M, and an operating cash inflow of $569.88K. Revenue of $61.79M sets the scale for evaluating how effectively sales translated into profit and cash during the year. Revenue was 36.2% below fiscal 2024 revenue of $96.91M, marking a top-line contraction. The company reported diluted EPS of $18.04, adding a shareholder-level measure to the absolute income figures considered below. Diluted EPS decreased by 54.5% from $39.62 in fiscal 2024, showing how the earnings change reached shareholders on a per-share basis. Revenue equaled 0.3x of total assets, indicating how much reported top-line activity the company produced relative to its period-end asset base.

Profitability

Gross profit was $19.16M, representing the portion of revenue remaining after the reported cost of revenue and before operating expenses. The gross-profit relationship equaled 31.0% of revenue, quantifying the portion retained before operating expenses were recognized. The reported operating result was $8.28M, capturing profitability after direct costs and the operating expenses reflected in the statements. Operating margin measured 13.4%, showing the portion of revenue preserved after the full set of operating costs. After all reported below-operating-line items, the company recorded net income of $6.78M for the fiscal year. Net margin was 11.0%, meaning that this portion of revenue remained as net income after all recognized expenses. Before income taxes, the company reported $9.41M of earnings, providing a bridge between the operating result and final net income. Pretax income represented 15.2% of revenue, placing earnings before tax in the context of the company’s operating scale. The company recognized $2.62M of income tax for the period, completing the transition from pretax income to net income. The income-tax provision equaled 27.9% of pretax income, showing the tax burden absorbed by the year’s earnings. Return on period-end equity was 3.6%, relating annual net income to the equity capital on the balance sheet.

Liquidity and Capital Structure

The company held $207.18M of assets against $18.25M of liabilities and $188.93M of equity, revealing how the asset base was financed. Current assets were $153.58M against $18.25M of current liabilities, framing the resources and obligations classified within the near-term balance-sheet horizon. At 8.42x, the current ratio shows that short-term assets were greater than short-term liabilities at period end. The company held $15.15M in cash and equivalents, a narrower liquidity measure than total current assets. Cash and equivalents represented 83.0% of current liabilities, showing the portion of near-term obligations matched by reported cash alone. Relative to total assets, liabilities measured 8.8%, complementing the separate equity-based view of the company’s capital structure. Measured against total assets, cash and equivalents represented 7.3%, a balance-sheet composition measure rather than a liquidity forecast. Total assets were 11.2% higher than fiscal 2024 assets of $186.24M, measuring the company’s own balance-sheet change.

Cash Flow and Earnings Quality

Cash flow from operations was $569.88K, a reported cash inflow that can be compared directly with net income and capital spending. The operating-cash-flow-to-net-income relationship was 0.08x, comparing cash generated by operations with the bottom-line earnings result. Capital expenditures used $15.63K, identifying the reported investment outflow deducted from operating cash flow in the free-cash-flow calculation. Capital spending absorbed 2.7% of operating cash flow, quantifying the share of cash from operations directed to investment. After capital spending, free cash flow was $554.25K, leaving cash available for debt reduction, shareholder returns, or further investment. Free cash flow represented 0.9% of revenue, linking post-investment cash generation with the company’s operating scale. Measured against total assets, free cash flow represented 0.3%, showing the cash productivity of the company’s assets.

Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated Sep 24, 2026.